AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

EXOPHARM LTD

0.028

0.000

Volume:- -

Turnover:- -

Market Cap:2.65M

PE:-2.40

High:0.028

Open:0.028

Low:0.028

Close:0.028

Loading ...

Overview Company News Filings

Company Profile

Company Name:

EXOPHARM LTD

Exchange:

ASX

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.exopharm.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Exopharm Limited, a biopharmaceutical company, focuses on developing and commercializing human therapeutics in Australia. The company is Plexaris and Exomere products, including non-clinical, pre-clinical, and clinical testing for other medical conditions, such as dry age-related macular degeneration and osteoarthritis. Exopharm Limited was founded in 2013 and is headquartered in Melbourne, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/EX1.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EX1.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EX1.AU\",,,,,undefined,":{"symbol":"EX1.AU","market":"AU","secType":"STK","nameCN":"EXOPHARM LTD","latestPrice":0.0275,"timestamp":1751608800000,"preClose":0.0275,"halted":0,"volume":0,"delay":0,"nameEN":"EXOPHARM LTD","floatShares":51335521,"shares":96419347,"eps":-0.011441732092348085,"marketStatus":"Closed","change":0,"latestTime":"07-04 16:00:00 AEST","open":0.0275,"high":0.0275,"low":0.0275,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.011441732092348085,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1751846400000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.0275,"openAndCloseTimeList":[[1751587200000,1751608800000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EX1.AU\",,,,,undefined,":{"symbol":"EX1.AU","floatShares":51335521,"roa":"-55.90%","roe":"-121.54%","lyrEps":-0.06328,"shares":96419347,"dividePrice":0,"high":0.0275,"amplitude":0,"preClose":0.0275,"low":0.0275,"week52Low":0.0275,"pbRate":"-0.13","psRate":"2.24","week52High":0.0275,"institutionHeld":0,"latestPrice":0.0275,"eps":-0.011441732092348085,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.011441732092348085,"open":0.0275,"prevYearClose":0.0275,"prevWeekClose":0.028,"prevMonthClose":0.028,"prevQuarterClose":0.028,"fiveDayClose":0.028,"twentyDayClose":0.028,"sixtyDayClose":0.028},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.exopharm.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0031},{"period":"1month","weight":-0.0068},{"period":"3month","weight":0.0365},{"period":"6month","weight":0.1364},{"period":"1year","weight":0.2144},{"period":"ytd","weight":0.1412}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Exopharm Limited, a biopharmaceutical company, focuses on developing and commercializing human therapeutics in Australia. The company is Plexaris and Exomere products, including non-clinical, pre-clinical, and clinical testing for other medical conditions, such as dry age-related macular degeneration and osteoarthritis. Exopharm Limited was founded in 2013 and is headquartered in Melbourne, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.207955},{"month":2,"riseRate":0,"avgChangeRate":-0.121006},{"month":3,"riseRate":0.833333,"avgChangeRate":0.350455},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.079183},{"month":5,"riseRate":0.2,"avgChangeRate":-0.120391},{"month":6,"riseRate":0.6,"avgChangeRate":0.114493},{"month":7,"riseRate":0.6,"avgChangeRate":0.017476},{"month":8,"riseRate":0.4,"avgChangeRate":0.018898},{"month":9,"riseRate":0.6,"avgChangeRate":-0.013494},{"month":10,"riseRate":0,"avgChangeRate":-0.085062},{"month":11,"riseRate":0.4,"avgChangeRate":0.031371},{"month":12,"riseRate":0.666667,"avgChangeRate":0.025547}],"exchange":"ASX","name":"EXOPHARM LTD","nameEN":"EXOPHARM LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"EX1.AU\",market:\"AU\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EX1.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-04-15","symbol":"EX1.AU","defaultRemindTime":1713139200000,"type":"split","dateTimestamp":1713103200000,"forFactor":5,"toFactor":2,"ratio":2.5},{"market":"AU","date":"2023-03-27","symbol":"EX1.AU","defaultRemindTime":1679871600000,"type":"split","dateTimestamp":1679835600000,"forFactor":884615,"toFactor":1000000,"ratio":0.884615}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EX1.AU\",market:\"AU\",,,undefined,":[]}}